Hepa Wash Awarded ZIM Grant
Published: Jan 18, 2011
Up to now dialysis fluids are manufactured in huge tanks of 5,000 liters or greater and are then filled into 5-liter-bags. The Hepa Wash production line will work continuously and the filling will be done immediately so that bulky mixing tanks are not necessary anymore. "The costs of the production will decline significantly", says Dr. Bernhard Kreymann, CEO of Hepa Wash GmbH. "With the in-house-production of the fluids we will be independent of suppliers and therefore even more competitive.”
Also the patient will significantly benefit from the innovation: The electrolyte household of treated patient is quite variable. Optimally each liver patient should get a dialysate specially adjusted according to the clinical picture. "Our production line will be able to produce individually tailored dialysates." says Kreymann.
About Hepa Wash GmbH
Hepa Wash GmbH, which is located in the "Munich Technology Center" (MTZ), works since its foundation in 2005 on a new liver support therapy, to reduce the high mortality of critically ill patients with liver failure. Recent studies revealed that existing therapies can hardly achieve any positive effects on survival of liver patients. However, the Hepa Wash procedure has a significantly increased detoxication capacity and is therefore expected to improve the survival rate of affected patients for at least 30 percent. Two in-vitro- and preclinical studies already showed the imposing beneficial effects of the procedure. The clinical study at II. Medical Clinic in Hospital rechts der Isar started in October 2010. For this study a TUEV approved prototype of the device is used. In parallel to the pilot study the company finishes the device for the CE certification.
More Informationen Description of Hepa Wash technology. Information about ZIM.
Daniela Becker, Hepa Wash GmbH, Agnes-Pockels-Bogen 1, 80992 München, Tel.: +49 (89) 4111842-24, Mail: firstname.lastname@example.org, Internet: www.hepawash.com